Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab-Reference-Cited by-同舟云学术

Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab

Published:2022-08 Issue: Volume:170 Page:58-64
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Gao Robert W.,Day Courtney N.,Yu Nathan Y.,Bush Aaron,Amundson Adam C.,Prodduturvar Pranitha,Majeed Umair,Butts Emily,Oliver Thomas,Schwecke Anna J.,Moffett Jenesse N.,Routman David M.,Breen William G.,Potter Ashley L.,Rivera-Concepcion Joel,Hoppe Bradford S.,Schild Steven E.,Sio Terence T.,Lou Yanyan,Ernani Vinicius,Ko Stephen,Olivier Kenneth R.,Merrell Kenneth W.,Garces Yolanda I.,Manochakian Rami,Harmsen William S.,Leventakos Konstantinos,Owen Dawn

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Long-term results of NRG oncology RTOG 0617: Standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer;Bradley;J. Clin. Oncol.,2020

2. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer;Antonia;N. Engl. J. Med.,2017

3. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC;Antonia;N. Engl. J. Med.,2018

4. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer;Spigel;J. Clin. Oncol.. Published online,2022

5. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis;Palma;Int. J. Radiat. Oncol. Biol. Phys.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer;Translational Lung Cancer Research;2024-05

3. An¹⁸F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non–Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy;Journal of Nuclear Medicine;2024-03-14

4. Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC;JTO Clinical and Research Reports;2024-03

5. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy;BMC Cancer;2024-02-23